# S9806: Combination Chemotherapy in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer

> **NCT00003587** · PHASE2 · COMPLETED · sponsor: **SWOG Cancer Research Network** · enrollment: 204 (actual)

## Conditions studied

- Lung Cancer

## Interventions

- **DRUG:** carboplatin
- **DRUG:** cisplatin
- **DRUG:** docetaxel
- **DRUG:** gemcitabine
- **DRUG:** paclitaxel
- **DRUG:** vinorelbine

## Key facts

- **NCT ID:** NCT00003587
- **Lead sponsor:** SWOG Cancer Research Network
- **Sponsor class:** NETWORK
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1998-10
- **Primary completion:** 2001-01
- **Final completion:** 2007-01
- **Target enrollment:** 204 (ACTUAL)
- **Last updated:** 2012-10-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00003587

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00003587, "S9806: Combination Chemotherapy in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00003587. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*